Baker Bros. Advisors’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q1 | – | Sell |
-152,964
| Closed | -$1.57M | – | 132 |
|
|
2016
Q4 | $1.57M | Sell |
152,964
-164,012
| -52% | -$1.69M | 0.02% | 97 |
|
|
2016
Q3 | $3.21M | Sell |
316,976
-153,082
| -33% | -$1.55M | 0.03% | 79 |
|
|
2016
Q2 | $5.28M | Sell |
470,058
-25,850
| -5% | -$290K | 0.06% | 71 |
|
|
2016
Q1 | $6.77M | Hold |
495,908
| – | – | 0.07% | 67 |
|
|
2015
Q4 | $9.41M | Hold |
495,908
| – | – | 0.08% | 62 |
|
|
2015
Q3 | $9.31M | Hold |
495,908
| – | – | 0.09% | 64 |
|
|
2015
Q2 | $7.38M | Hold |
495,908
| – | – | 0.06% | 70 |
|
|
2015
Q1 | $7.51M | Sell |
495,908
-9,510
| -2% | -$144K | 0.06% | 67 |
|
|
2014
Q4 | $6.73M | Buy |
505,418
+53,922
| +12% | +$718K | 0.07% | 65 |
|
|
2014
Q3 | $5.69M | Buy |
451,496
+52,696
| +13% | +$664K | 0.07% | 57 |
|
|
2014
Q2 | $4.03M | Buy |
+398,800
| New | +$4.03M | 0.05% | 77 |
|